Your browser doesn't support javascript.
loading
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125.
Glickman, Ariel; Paredes, Pilar; Carreras-Diéguez, Núria; Niñerola-Baizán, Aida; Gaba, Lydia; Pahisa, Jaume; Fusté, Pere; Del Pino, Marta; Díaz-Feijóo, Berta; González-Bosquet, Eduardo; Agustí, Núria; Sánchez-Izquierdo, Nuria; Fuster, David; Perissinotti, Andrés; Romero, Inmaculada; Fernández-Galán, Esther; Carrasco, Josep Lluís; Gil-Ibáñez, Blanca; Torné, Aureli.
  • Glickman A; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Paredes P; Department of Nuclear Medicine, Hospital Clínic Barcelona, Barcelona, Spain. pparedes@clinic.cat.
  • Carreras-Diéguez N; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. pparedes@clinic.cat.
  • Niñerola-Baizán A; Faculty of Medicine - University of Barcelona, Barcelona, Spain. pparedes@clinic.cat.
  • Gaba L; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Pahisa J; Department of Nuclear Medicine, Hospital Clínic Barcelona, Barcelona, Spain.
  • Fusté P; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Del Pino M; Faculty of Medicine - University of Barcelona, Barcelona, Spain.
  • Díaz-Feijóo B; Biomedical Research Networking Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
  • González-Bosquet E; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Agustí N; Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain.
  • Sánchez-Izquierdo N; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Fuster D; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Perissinotti A; Faculty of Medicine - University of Barcelona, Barcelona, Spain.
  • Romero I; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Fernández-Galán E; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Carrasco JL; Faculty of Medicine - University of Barcelona, Barcelona, Spain.
  • Gil-Ibáñez B; Gynaecologic Oncology Unit, Institut Clínic de GinecologiaObstetrícia i Neonatologia, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Torné A; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Eur Radiol ; 32(4): 2200-2208, 2022 Apr.
Article en En | MEDLINE | ID: mdl-34586465
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Fluorodesoxiglucosa F18 Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article